What is Buscopan®?
Buscopan® is an antispasmodic medication which specifically relieves stomach pain with cramps.
Buscopan® works directly on the muscles where cramps occur, relaxing them and relieving stomach pain.. With Buscopan®, you can be confident that you are targeting the site of stomach cramps.
Buscopan® is the #1 selling medicine available in pharmacy for stomach pain with cramps1.
What are the differences between Buscopan® and a general pain reliever? (paracetamol/ibuprofen)?
Buscopan® acts only where the cramps and pains occur – in the stomach & bowel (digestive tract) and has a two way action to relax cramps and relieve pain. General pain relievers work differently by blocking pain signals, thereby relieving stomach pain. They do not relax cramping muscles.
How do I take Buscopan®?
It is recommended to swallow Buscopan® tablets whole (do not crush) and with plenty of water. For more information, please refer to the Consumer Medicine Information leaflet inside the pack or consult your doctor or pharmacist.
Can Buscopan be taken during pregnancy or lactation?
Buscopan® is not recommended during pregnancy and breastfeeding. If you are suffering from stomach pain with cramps and are pregnant or breastfeeding, you should consult your doctor.
What causes stomach pain with cramps?
Common causes of stomach pain with cramps include:
- Sensitivity to certain foods that trigger stomach pain, such as fatty, spicy or highly seasoned foods, caffeine, alcohol and acidic citrus fruits.
- A hectic, stress-filled lifestyle, skipping meals, eating on the run and anxiety.
- A change from your normal daily routine, for example when travelling, which can unbalance your digestive system.
What is the difference between stomach cramps and IBS?
IBS sufferers can experience stomach pain and cramps as well. However, IBS patients will often experience other symptom including diarrhoea and/or constipation and/or flatulence. If you suffer from IBS, you should consult with your doctor before using any treatment.
- IRI Pharmacy Scan, MAT 18/3/2018, Value & Volume sales, Antispasmodics.